期刊文献+

VEGF、VEGF-C、flt-4在乳腺癌组织中的表达及临床病理分析 被引量:5

Expression of vascular endothelial growth factors VEGF, VEGF-C and flt-4 in breast cancer and its clinical pathological analysis
下载PDF
导出
摘要 目的:探讨乳腺癌组织中VEGF、VEGF-C、flt-4蛋白的表达水平、相互关系及临床意义。方法:采用免疫组织化学ABC法,检测82例乳腺癌石蜡标本中VEGF、VEGF-C、flt-4蛋白的表达水平。结果:乳腺癌标本中VEGF、VEGF-C、flt-4蛋白的阳性表达率分别为57.3%、46.3%、50.0%,VEGF-C与flt-4蛋白的表达呈正相关。但与乳腺癌组织病理学分型、肿瘤大小和分级无关。结论:VEGF-C、flt-4蛋白的表达与乳腺癌淋巴结转移有关,并可能协同作用于淋巴结转移过程。 Purpose: To study the expression of VEGF, VEGF-C, fit-4 in breast cancer and its relationship with lymph node metastasis and explore the significance of lymphangiogenesis on metastasis via lymphtics. Methods: Paraffin-embedded specimens from 82 patients with primary breast cancer who had undergone radical mastectomy with lymph node dissection were studied. VEGF, VEGF-C, flt-4 expression were investigated by immunohistochemical staining. Results: Positive staining for VEGF, VEGF-C, flt-4 were observed in some breast cancer cells. Furthermore, the expression of VEGF-C, flt-4 were significantly higher in lymph node-positive group than in node-negative group. Correlation was found within the expression of VEGF-C, flt4 also. Conclusions: Clinical significance was found between VEGF-C, flt-4 expression and lymph-node metastasis in breast cancer, and may be involved in the metastatic process.
出处 《中国癌症杂志》 CAS CSCD 2003年第4期326-328,共3页 China Oncology
关键词 VEGF VEGF-C fit-4 乳腺癌 表达 病理分析 癌组织 breast neoplasms VEGF VEGF-C flt-4 immunohistochemistry
  • 相关文献

参考文献12

  • 1Fleming ST, Rastogi A, Demtrienko A, et al. A comprehensive prognostic index to predict survival based on multiple comborbidities: a focus in breast cancer[J]. Mett Care, 1999,37(6) :601-604.
  • 2Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis[J]. Nature Med,2001,7(2) :192-198.
  • 3Karpanen T, Egeblad N, Karkkainen M J, et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth[J]. Cancer Res,2001,61 ( 5 ) :1786-1790.
  • 4Peppers MS. Lymphangiogenesis and tumor metastasis: myth or reality[J] ? Clin Cancer Res,2001,7(3) :462-468.
  • 5Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis[ J ]. Physiol Rev,2002,82( 3 ) :673-700.
  • 6Stimpfl M, Tong D, Fasching B, et al. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer [J]. Clin Cancer Res,2002,8(7):2253-2259.
  • 7Nakamura M, Abe Y, Tokunaga T. Pathological significance of vascular endothelial growth factor A isoform expression in human cancer[J]. Pathol Int,2002,52( 5-6 ) :331-339.
  • 8Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothefial growth factor, VEGF-C, is a ligand for the Flt-4(VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases[J]. EMBO J,1996,15(2) :290-298.
  • 9Karkkainen MJ, Petrova TV. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis[J]. Oncogene,2000,19(49) :5598-5605.
  • 10Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice[J]. Science,1997, 276(5317):1423-1425.

同被引文献61

  • 1唐瑞峰,王曙霞,张风瑞,王顺祥,彭利,张萌,肖燕.TNF-α和低氧对胰腺癌细胞表达VEGF-A、C的调节[J].中国肿瘤临床,2005,32(15):852-855. 被引量:2
  • 2唐瑞峰,王曙霞,彭利,王顺祥,张萌,肖燕,张风瑞.细胞因子和低氧对胰腺癌细胞表达血管内皮生长因子A、C的调节[J].肿瘤,2007,27(1):30-33. 被引量:2
  • 3Kedra B, Popiela T, Sierzega M, et al. Prognostic factors of long- term survival after resective procedures for pancreatic cancer[J]. Hepatoga-stroenterology, 2001,48 ( 42 ) : 1762-1766.
  • 4Benassai G, Mastrorilli M, Quarto G, et al. Factors influencing survival after resection for ductal adeno-carcinoma of the head of the pancreas[J]. J Surg Oncol,2000,73(4) :212-218.
  • 5Kuhlmann KF, DE Castro SM, Wesseling JG, et al. Surgical treatment of pancreatic adenocarcinoma: actual survival and prognostic factors in 343 patients[J]. Eur J Cancer, 2004, 40 (4) : 549-558.
  • 6Veikkola T,Jussila I., Makinen T, et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphan- giogenesis in transgenic mice[J]. EMBO J,2001,20(6):1223-1231.
  • 7Nathanson SD,Zarbo R J, Wachna DL, et al. Microvessels that prodict axillary lymph node metastases in patients with breast cancer[J]. Arch Surg, 2000, 135 (5) : 586-593.
  • 8Salven P, Hattori K, Heissing B, et al. Interleukin-1alpha promotes angiogenesis in vivo VEGF-VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion[J]. FASEB J,2002,16(11 ) : 1471-1473.
  • 9Cohen T,Nahari D,Cerem LW,et al. Interleukin 6 induces the expression of vascular endothelial growth factor [J]. J Biol Chem, 1996,271 (2): 736-741.
  • 10Huang SP, Wu MS, Shun CT, et al. Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma[J]. J Biomed Sci, 2004,11 (4) : 517-527.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部